检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:嵇虎
机构地区:[1]江苏省淮安市涟水县人民医院内科,江苏淮安223400
出 处:《中外医疗》2017年第31期116-117,120,共3页China & Foreign Medical Treatment
摘 要:目的分析泼尼松联合维血宁治疗特发性血小板减少紫癜临床疗效。方法方便选择该院自2011年1月—2017年3月收治的90例特发性血小板减少紫癜患者,将其随机分为2组,对照组和观察组,每组45例。对照组患者给予波尼松治疗,观察组患者给予波尼松联合维血宁治疗,对两组患者治疗效果进行比较。结果观察组患者有效率为91.11%明显高于对照组71.11%,相对比差异有统计学意义(P<0.05)。经治疗后,观察组患者血小板计数与对照组对比,前者显著高于后者(P<0.05);治疗后观察组患者的血小板计数为(102.87±22.37)×109/L。两组患者血小板开始回升时间、达到顶峰时间观察组明显短于对照组,差异有统计学意义(P<0.05);观察组血小板开始上升的时间为(3.62±1.76)d,在(8.73±2.87)d达到峰值。结论要在短时间内将特发性血小板减少紫癜患者血小板数目提升,将出血时间缩短,泼尼松联合维血宁治疗是不错的选择。Objective To analyze the clinical curative effect of prednisone and weixuening granules in treatment of idiopathic thrombocytopenic purpura. Methods 90 cases of patients with idiopathic thrombocytopenic purpura admitted and treated in our hospital from January 2011 to March 2017 were convenient selected and randomly divided into two groups with 45 cases in each, th control group were treated with prednisone, while the observation group were treated with prednisone and weixuening granules, and the treatment effect was compared between the two groups. Results The effective rate in the observation group was obviously higher than that in the control group(91.11% vs 71.11%),(P<0.05), and the blood platelet count in the observation group after treatment was higher than that in the control group(P<0.05), which was(102.87±22.37)×109/L in the observation group after treatment, and the rise time of blood platelet and peak reaching time in the observation group were obviously shorter than those in the control group(P<0.05), and the starting time of blood platelet risk was(3.62 ±1.76)d in the observation group, reaching the peak value at(8.73 ±2.87)d. Conclusion prednisone and weixuening granules treatment is a good choice to improve the blood platelet count of patients with idiopathic thrombocytopenic purpura in a short time and shorten the bleeding time.
关 键 词:泼尼松 维血宁 特发性血小板减少紫癜 临床疗效
分 类 号:R554[医药卫生—血液循环系统疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.233